-Kafila.org Dear Prime Minister Modi ji, We, the undersigned, wish to share with you some of our concerns on India's position on intellectual property (IP), particularly in the context of bilateral relations between the United States of America and India. We gather from the US-India Joint Statement dated 30 September 2014 that the Indian Government (a)greeing on the need to foster innovation in a manner that promotes economic growth...

-The Economic Times NEW DELHI: It had been expected to dilute the UPA government's showpiece Right to Information (RTI) Act that had become a scourge of sorts for its ministers and bureaucrats and was even blamed by some as a contributing factor for the policy paralysis during its reign. But the Narendra Modi-led BJP government has done the reverse and taken RTI to quite another level. Starting next month, all replies...

-The Hindu Court rejects argument that disclosing names will violate right to privacy The Supreme Court made it clear to the Centre on Tuesday that it could not take shelter under the confidentiality clause for not disclosing all names of black-money account holders it had received from abroad. At the outset, Attorney-General Mukul Rohatgi told the court, "We (government) are not Interested in hiding any information from the court. This government constituted the...

-The Hindu Business Line The Government has constituted an Intellectual Property Rights (IPR) think-tank to help draft a new National IPR Policy and to advice it on issues related to intellectual property. The think-tank, headed by Justice Prabha Sridevan, will highlight anomalies in the present IPR legislations and advice the Department of Industrial Policy and Promotion (DIPP) on possible solutions, according to an official release. It will also provide views on the possible...

-Livemint The petition challenged NPPA's decision of withdrawing its internal guideline to set prices of non-essential drugs New Delhi: The Supreme Court on Monday refused to entertain a petition challenging a decision by the country's drug price regulator to withdraw its internal guideline to set prices of non-essential drugs. Earlier this year, the National Pharmaceutical Pricing Authority (NPPA) issued a guideline empowering itself to cap the prices of 108 non-essential drugs, attracting...